Elsevier

Maturitas

Volume 31, Issue 2, 4 January 1999, Pages 161-164
Maturitas

A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen–progestin therapy

https://doi.org/10.1016/S0378-5122(98)00114-5Get rights and content

Abstract

Objectives: To investigate the effect of vitamin K2 treatment for a year on spinal bone mineral density (BMD) in postmenopausal women, comparing with vitamin D3 hormone replacement therapy and to determine the factors which affect the efficacy of vitamin K2 therapy. Subjects and methods: Seventy-two postmenopausal women were randomized into four groups and treated with respective agents. Before the therapy, 6 and 12 months after the treatment, their lumbar spine BMD were measured by dual energy X-ray absorptiometry. The rates of change in BMD (ΔBMD) were calculated. Correlations of BMD with age, year since menopause and the initial BMD were determined. Results: Vitamin K2 suppressed the decrease in spinal BMD as compared with no treatment group. BMD in women treated with vitamin K2 was inversely correlated with their age (r=−0.54; P<0.05). Conclusions: Vitamin K2 therapy may be a useful method for preventing postmenopausal spinal bone mineral loss. In addition, the therapy should be started early in postmenopausal period.

Introduction

Several agents including vitamin D3, estrogen, calcitonin, and bisphosphonate, etc have been used for preventing postmenopausal osteoporosis. But, in clinical practice, there are some people who respond poorly or little to those medicines. Recently, much attention have been paid to vitamin K2 because of its action on bone; vitamin K2 both increases bone formation and decreases bone resorption.

Since Bouckaert and Said first reported the effect of vitamin K on fracture healing in 1960 [1], many studies have suggested that vitamin K is closely related with bone metabolism [2], [3]. In our country, vitamin K2 (menatetrenone) has been accepted for clinical application in the treatment of osteoporotic osteopenia from 1995. Orimo et al. [4] reported that vitamin K2 increases the bone mineral density (BMD) of cortical bones in elderly osteoporotic patients. However, to prevent bone fracture, cancellous bones should be examined than the cortical ones. In addition, to prevent osteoporosis effectively, the therapy ought to be started earlier than elderly age. There are very few reports about vitamin K2 therapy so far. Our study is the first report which investigated the BMD of cancellous bones in women just after menopause. In the present study, we performed a longitudinal study of the effect of vitamin K2 on vertebral bone in postmenopausal women for 12 months, comparing with vitamin D3 or estrogen-progestins treatment (HRT). Moreover, we investigated the relationship of the rates of change in BMD (BMD) with age, years since menopause (YSM) and initial BMD of the women who were treated by each regimen.

Section snippets

Subjects and methods

A total of 72 healthy, non-hysterectomized postmenopausal women who had visted at the outpatient clinic of the Department of Obstetrics and Gynecology, Kagoshima University in Kagoshima, between 1994 and 1996 were selected. Postmenopausal state was defined as the absence of menstruation for at least 12 months. All subjects had no medications and complications, which affected bone metabolism and had no unbalanced diet for vitamin K rich food, e.g. green vegetables and fermented foods. All

Results

Table 1 shows the baseline characteristic of the subjects. There was no significant difference in age, BMI, YSM, and the initial BMD among the groups. Fig. 1 presents the rates of change in BMD (BMD) in each group during the treatment study. The mean±S.E.M of BMD (%) at 12 months were (−2.87±0.51) in control, (0.23±0.47) in vitamin K2 group, (−0.47±0.86) in vitamin D3 group and (4.0±1.12) in HRT group. There was significant difference in BMD between HRT group and control group (P<0.01).

Discussion

There have been many reports in regard to the effect of HRT on BMD; it is generally recognized that HRT has a suppressive effect on bone loss and an enhancing effect of increasing BMD at lumbar spine in postmenopausal women [5]. In the present study, HRT also prevented bone mineral loss. Thus, it is certain that HRT is a good way for preventing osteoporosis. However, HRT has some adverse effects, for example, increasing the risk of thromboembolism. There are some alternative agents for

Cited by (72)

  • Update on nutrients involved in maintaining healthy bone

    2013, Endocrinologia y Nutricion
    Citation Excerpt :

    In the Framingham Offspring Study, a relevant cross-sectional study, Booth et al.32 reported a significant positive association between vitamin K intake and spine and hip BMD in women. As regards the intervention study in humans, Iwamoto et al. demonstrated that a vitamin K2 supplement suppressed the decrease in spinal BMD, as compared with no treatment group in postmenopausal women (Table 1).33 The effect of vitamin K and D supplementation on BMD was compared with the effect of calcium and vitamin D by Iwamoto et al.34 The results of this study indicate that combined administration of vitamin D3 and vitamin K2, compared with calcium administration, appears to be useful in increasing the BMD of the lumbar spine in postmenopausal women with osteoporosis (Table 1).

  • Nutraceuticals and their role in promoting musculoskeletal healthy aging

    2023, Annali di Igiene Medicina Preventiva e di Comunita
View all citing articles on Scopus
View full text